Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2005 1
2006 1
2010 1
2011 2
2012 1
2013 1
2015 1
2016 1
2017 1
2018 3
2019 2
2020 3
2021 4
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens.
Zhu Y, Zhu L, Davies Forsman L, Paues J, Werngren J, Niward K, Schön T, Bruchfeld J, Xiong H, Alffenaar JW, Hu Y. Zhu Y, et al. Among authors: paues j. Antimicrob Agents Chemother. 2023 May 17;67(5):e0170022. doi: 10.1128/aac.01700-22. Epub 2023 Apr 25. Antimicrob Agents Chemother. 2023. PMID: 37097151 Free PMC article.
Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay.
Niward K, Ek Blom L, Davies Forsman L, Bruchfeld J, Eliasson E, Schön T, Chryssanthou E, Paues J. Niward K, et al. Among authors: paues j. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e00218-18. doi: 10.1128/AAC.00218-18. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29483112 Free PMC article.
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
Pérez-Recio S, Pallarès N, Grijota-Camino MD, Sánchez-Montalvá A, Barcia L, Campos-Gutiérrez S, Pomar V, Rabuñal-Rey R, Balcells ME, Gazel D, Montiel N, Vicente D, Goić-Barišić I, Schön T, Paues J, Mareković I, Cacho-Calvo J, Barac A, Goletti D, García-Gasalla M, Barcala JM, Tórtola MT, Anibarro L, Suárez-Toste I, Moga E, Gude-Gonzalez MJ, Naves R, Karslıgil T, Martin-Peñaranda T, Stevanovic G, Trigo M, Rubio V, Karaoğlan İ, Bayram N, Alcaide F, Tebé C, Santin M; ESCMID Study Group for Mycobacterial Infections (ESGMYC) and the Mycobacteria Study Group (GEIM) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Pérez-Recio S, et al. Among authors: paues j. Microbiol Spectr. 2021 Dec 22;9(3):e0097221. doi: 10.1128/Spectrum.00972-21. Epub 2021 Nov 10. Microbiol Spectr. 2021. PMID: 34756079 Free PMC article.
Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP).
Ekqvist D, Bornefall A, Augustinsson D, Sönnerbrandt M, Nordvall MJ, Fredrikson M, Carlsson B, Sandstedt M, Simonsson USH, Alffenaar JC, Paues J, Niward K. Ekqvist D, et al. Among authors: paues j. BMJ Open. 2022 Mar 10;12(3):e054788. doi: 10.1136/bmjopen-2021-054788. BMJ Open. 2022. PMID: 35273049 Free PMC article.
28 results